MARKET

HAE

HAE

Haemonetics Corp Mass
NYSE
81.98
+0.04
+0.05%
Closed 18:53 11/27 EST
OPEN
81.46
PREV CLOSE
81.94
HIGH
82.28
LOW
80.94
VOLUME
349.60K
TURNOVER
0
52 WEEK HIGH
95.26
52 WEEK LOW
72.26
MARKET CAP
4.16B
P/E (TTM)
32.70
1D
5D
1M
3M
1Y
5Y
Haemonetics (HAE) Stock Up 4.2% YTD: Will the Rally Continue?
NASDAQ · 1d ago
Haemonetics' (HAE) Plasma Growth, Innovation Aid Performance
NASDAQ · 1d ago
Top buy and top sell ideas in each sector – Oppenheimer
Oppenheimer's technical analysis report highlights top buy ideas across mid- to small-caps stocks relative to the russell 2000. The report shows what to buy and sell in each sector. Buy and sell ideas in energy: buy par pacific holdings inc., sell nabors industries ltd.
Seeking Alpha · 1d ago
Here's Why Investors Should Retain Labcorp (LH) Stock for Now
NASDAQ · 1d ago
Weekly Report: what happened at HAE last week (1120-1124)?
Weekly Report · 1d ago
Orthofix (OFIX) Q3 Earnings Top Estimates, 2023 Sales View Cut
NASDAQ · 4d ago
Labcorp (LH) Closes the Legacy Health Asset Acquisition Deal
NASDAQ · 4d ago
EssilorLuxottica (ESLOY), Moncler Ink Luxury Eyewear Deal
NASDAQ · 5d ago
More
About HAE
Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. The Company markets and sells its products in approximately 90 countries.

Webull offers Haemonetics Corporation stock information, including NYSE: HAE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HAE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HAE stock methods without spending real money on the virtual paper trading platform.